Initial Approach to Treating Nocturnal Enuresis in Pediatric Patients
The initial approach to treating nocturnal enuresis in pediatric patients should begin with general lifestyle advice and behavioral modifications before considering pharmacological interventions or alarm therapy. 1
Initial Assessment
Before starting treatment, consider:
- Age of the child (active treatment typically not started before age 6) 1
- Type of enuresis (monosymptomatic vs. non-monosymptomatic)
- Frequency of wet nights
- Previous treatments attempted
- Impact on quality of life and psychological well-being
Key diagnostic steps:
- Urinalysis (mandatory to rule out diabetes mellitus, urinary tract infection) 1
- Frequency-volume chart or bladder diary for at least 1 week 1
- Assessment for constipation, which often coexists with enuresis 1
First-Line Interventions: General Lifestyle Advice
Education and reassurance:
Tracking progress:
- Implement a calendar/chart of dry and wet nights
- This serves both as baseline measurement and has an independent therapeutic effect 1
Voiding regimen:
Fluid management:
Constipation management:
- Treat any existing constipation
- Aim for soft daily bowel movements
- Consider polyethylene glycol if needed 1
Physical activity:
- Encourage regular physical activity 1
Second-Line Interventions
If no improvement after 3 months of consistent lifestyle modifications, consider:
Enuresis alarm therapy:
- Most effective non-pharmacological intervention with 66% initial success rate and lower relapse rates than medication 1
- Requires significant parental involvement to wake child when alarm sounds 1
- Most suitable for motivated families with good support systems 1
- Consider for children with frequent enuresis 1
Desmopressin:
- Evidence-based pharmacological option (grade Ia evidence) 1
- Approximately 30% full response rate and 40% partial response 1
- Most effective for children with nocturnal polyuria (urine production >130% of expected bladder capacity) 1
- Oral formulations preferred (tablets or melt formulation) 1
- Dosage: 0.2-0.4 mg tablets or 120-240 μg melt formulation 1
- Safety precaution: limit evening fluid intake to 200 ml or less to prevent water intoxication 1
Imipramine (less commonly used):
- For children aged 6 and older: initial dose 25 mg/day one hour before bedtime 3
- May increase to 50 mg for children under 12 years; up to 75 mg for children over 12 3
- Do not exceed 2.5 mg/kg/day 3
- Significant relapse rate (up to 50%) when discontinued 1
- Cardiac monitoring recommended due to potential arrhythmia risk 3
Common Pitfalls and Caveats
Waking the child to urinate:
Medication discontinuation:
Alarm therapy failures:
Desmopressin safety:
Basic bladder advice limitations:
Treatment Algorithm
- Start with general lifestyle advice for all children (age 6+)
- Maintain for 3 months with monthly follow-up
- If insufficient response after 3 months:
- For children with nocturnal polyuria: Consider desmopressin
- For children with normal urine production: Consider alarm therapy
- For families with high motivation and support: Consider alarm therapy
- For families with limited support or compliance issues: Consider desmopressin
Remember that the goal of treatment is to improve quality of life by reducing the frequency of wet nights and minimizing psychological impact, while working toward complete dryness.